Based at Karolinska Institute Science Park, Stockholm Sweden
Investor Invitation We are excited to invite you to our first Investor Forum monday the 30th of january at the Karolinska Institute, Huddinge, Sweden. On…
News Euroclear Sweden AUXESIS PHARMA HOLDING AB (publ) register of shareholders is in process of being digitalised and transferred to the Euroclear system. As a client…
Update There is exciting news in Auxesis Pharma. Trademarks, new areas of application, clinical studies and trials, production facilities, to name a few. Complete pdf…
Investor Invitation We are excited to invite you to our first Investor Forum monday the 30th of january at the Karolinska Institute, Huddinge, Sweden. On…
News Euroclear Sweden AUXESIS PHARMA HOLDING AB (publ) register of shareholders is in process of being digitalised and transferred to the Euroclear system. As a client…
Update There is exciting news in Auxesis Pharma. Trademarks, new areas of application, clinical studies and trials, production facilities, to name a few. Complete pdf…
Our Team
AUXESIS PHARMA HOLDING AB (publ), is a pharmaceutical company, based in Stockholm, Sweden. The team is interdisciplinary in the medical industry including a Certified Drug Consultant, Professor of Pharmacotherapy, Clinical Pharmacology and Sales and Marketing expertise. Auxesis Pharma Holding AB is a company that owns the rights of any additional and necessary patents in a specific medical research area.
Our product line
Our product line are designed for the global market. The company is working with the FDA for a second introduction to the US market, and are negotiating with strategic pharmaceutical companies for manufacturing and distribution. The active substances of our products has already been approved by the Medical Products Agency in Sweden, which will simplify the process for approval both domestically and globally.
Product in focus
ASA.P® is a non-perscription topical pain elimination drug that can be applied to the skin in different forms. The global challange today is quick pain relief for topical exposure and infections from sun burn, wasp/ mosquito bites, herpes, nettle, jelly fish etc. Our research reveals that it drastically deminishes pain caused by insect bites, poison plants, rashes, eczema, herpes etc in its own, unique way.
Investor Hub
News and updates from Auxesis Pharma for the Investor Hub exclusively. Documentation available for download.
Partners
+46 (0)8-771 43 00
Copyright All rights reserved AUXESIS PHARMA HOLDING AB (publ) 2023